Technology
Health
Biotechnology

X4 Pharmaceuticals

$14.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.58 (-3.74%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell XFOR and other stocks, options, ETFs, and crypto commission-free!

About

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Read More Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.

Employees
15
Headquarters
Cambridge, Massachusetts
Founded
Market Cap
104.23M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
106.93K
High Today
$15.95
Low Today
$14.93
Open Price
$15.51
Volume
11.65K
52 Week High
$112.44
52 Week Low
$6.90

Collections

Technology
Health
Biotechnology
2017 IPO
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.